T. Rowe Price Associates’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $77K | Buy |
|
|||||
|
2024
Q1 | $77K | Hold |
|
|||||
|
2023
Q4 | $55K | Hold |
|
|||||
|
2023
Q3 | $26K | Hold |
|
|||||
|
2023
Q2 | $45K | Hold |
|
|||||
|
2023
Q1 | $48K | Sell |
|
|||||
|
2022
Q4 | $257K | Sell |
|
|||||
|
2022
Q3 | $597K | Hold |
|
|||||
|
2022
Q2 | $236K | Sell |
|
|||||
|
2022
Q1 | $1.33M | Sell |
|
|||||
|
2021
Q4 | $8.52M | Buy |
|
|||||
|
2021
Q3 | $11.1M | Sell |
|
|||||
|
2021
Q2 | $18.2M | Sell |
|
|||||
|
2021
Q1 | $38.5M | Buy |
|
|||||
|
2020
Q4 | $27.9M | Buy |
|
|||||
|
2020
Q3 | $17.3M | Sell |
|
|||||
|
2020
Q2 | $38.3M | Buy |
|
|||||
|
2020
Q1 | $16.4M | Sell |
|
|||||
|
2019
Q4 | $47.6M | Sell |
|
|||||
|
2019
Q3 | $41.5M | Buy |
|
|||||
|
2019
Q2 | $43.7M | Sell |
|
|||||
|
2019
Q1 | $24.7M | Sell |
|
|||||
|
2018
Q4 | $32.5M | Sell |
|
|||||
|
2018
Q3 | $102M | Buy |
|
|||||
|
2018
Q2 | $60.5M | Buy |
|
|||||
|
2018
Q1 | $41.3M | Buy |
|